Sulzer is a global partner offering reliable and sustainable solutions for performance-critical applications. Our innovative solutions add value and strengthen the competitive position of our customers.

Simcro, headquartered in Hamilton, New Zealand, is expected to achieve revenues of CHF 35 million and an EBITDA margin of 27% in 2017. The company generates 30% of its revenues in Europe, Middle East, and Africa; 40% in the Americas; and 30% in Asia-Pacific.

It employs 230 people. Simcro operates two manufacturing locations - one in New Zealand and one in Australia - and focuses on B2B customers. Its delivery systems inject or orally apply pharmaceuticals to livestock and companion animals. Simcro's proprietary intellectual property includes enhancing treatment efficacy, user safety, operational convenience, and animal welfare.

Simcro will become part of Sulzer's Applicator Systems division, and its current management team will stay with the company. Following the acquisitions of PC Cox and Geka in 2016, Simcro is Sulzer's third acquisition to strengthen its Applicator Systems division. The transaction is expected to close in the third quarter of 2017 subject to foreign investment approval in New Zealand.